摘要 |
<p>There are provided intermediates used to prepare a derivative, (3R,5R)-7-[2-(4-fluorphenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-lH-pyrrol-l-yl]-3,5-di hydroxyheptanoic acid, which has an effect to suppress cholesterol in blood, and a process for preparing pyrrolylheptanoic acid derivatives therefrom. In accordance with the present invention, the 5-(4-fluorphenyl)-2-isopropyl-4-phenyl-lH-pyrrole-3-carbonyl derivative is provided as one of the novel synthetic intermediates that are used to prepare pyrrolylheptanoic acid derivatives including a derivative, (3R,5R)-7-[2-(4-fluorphenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-lH-pyrrol-l-yl]-3,5-di hydroxyheptanoic acid. Therefore, the (3R,5R)-7-[2-(4-fluorphenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-lH-pyrrol-l-yl]-3,5-di hydroxyheptanoic acid derivative may be prepared from the carbonyl derivative in a high yield for a short time period under a moderate condition.</p> |
申请人 |
DONG-A PHARM.CO., LTD.;KIM, MOON-SUNG;YOO, MOO-HI;RHEE, JAE-KEOL;KIM, YONG-JIK;PARK, SEONG-JIN;CHOI, JUN-HO;SUNG, SI-YOUNG;LIM, HONG-GYU;CHA, DAE-WON |
发明人 |
KIM, MOON-SUNG;YOO, MOO-HI;RHEE, JAE-KEOL;KIM, YONG-JIK;PARK, SEONG-JIN;CHOI, JUN-HO;SUNG, SI-YOUNG;LIM, HONG-GYU;CHA, DAE-WON |